Qiagen NV Company Profile (NASDAQ:QGEN)

About Qiagen NV

Qiagen NV logoQIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, pharma and academia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: QGEN
  • CUSIP: N7248210
Key Metrics:
  • Previous Close: $27.12
  • 50 Day Moving Average: $26.75
  • 200 Day Moving Average: $23.49
  • 52-Week Range: $19.94 - $28.04
  • Trailing P/E Ratio: 54.24
  • Foreward P/E Ratio: 22.05
  • P/E Growth: 2.48
  • Market Cap: $6.35B
  • Outstanding Shares: 234,000,000
  • Beta: 0.9
Profitability:
  • Net Margins: 9.13%
  • Return on Equity: 9.21%
  • Return on Assets: 5.74%
Debt:
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 3.62%
  • Quick Ratio: 3.06%
Additional Links:
Companies Related to Qiagen NV:

Analyst Ratings

Consensus Ratings for Qiagen NV (NASDAQ:QGEN) (?)
Ratings Breakdown: 7 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $25.00 (7.82% downside)

Analysts' Ratings History for Qiagen NV (NASDAQ:QGEN)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2016DZ Bank AGReiterated RatingBuyView Rating Details
9/16/2016Commerzbank AGReiterated RatingBuyView Rating Details
9/11/2016Morgan StanleySet Price TargetBuy$30.00View Rating Details
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
8/1/2016HSBCUpgradeHold -> BuyView Rating Details
8/1/2016MizuhoBoost Price TargetNeutral$22.00 -> $25.00View Rating Details
7/29/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
7/25/2016Piper Jaffray Cos.Reiterated RatingNeutral$23.00View Rating Details
6/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00View Rating Details
2/3/2016Barclays PLCLower Price TargetOverweight$28.00 -> $27.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details
11/12/2015Stifel NicolausInitiated CoverageHoldView Rating Details
10/30/2015Goldman Sachs Group Inc.Lower Price Target$22.00 -> $21.00View Rating Details
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00View Rating Details
5/28/2015Credit Suisse Group AGReiterated RatingNeutral$24.00 -> $25.00View Rating Details
1/6/2015Bank of America Corp.DowngradeNeutral -> Underperform$26.00 -> $24.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Qiagen NV (NASDAQ:QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
4/25/2012$0.21$0.23ViewN/AView Earnings Details
1/31/2012$0.28$0.31ViewN/AView Earnings Details
11/2/2011$0.22$0.24ViewN/AView Earnings Details
7/25/2011$0.23$0.23ViewN/AView Earnings Details
4/27/2011$0.21$0.21ViewN/AView Earnings Details
1/31/2011$0.25$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Qiagen NV (NASDAQ:QGEN)
Current Year EPS Consensus Estimate: $1.09 EPS
Next Year EPS Consensus Estimate: $1.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.19$0.25$0.22
Q2 20164$0.25$0.29$0.27
Q3 20164$0.27$0.30$0.29
Q4 20163$0.33$0.39$0.36
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen NV (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen NV (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Qiagen NV (NASDAQ:QGEN)
DateHeadline
realistinvestor.com logoQiagen N.V. (NASDAQ:QGEN)'s Accounts Payable Is $45.563 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 26 at 6:59 PM
investornewswire.com logoQiagen N.V. (NASDAQ:QGEN) Quarterly EPS At $0.32 - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - September 26 at 6:59 PM
News IconCitigroup Inc. Cuts Qiagen NV Price Target to $28.00 (QGEN ... - Petro Global News 24 (NASDAQ:QGEN)
petroglobalnews24.com - September 23 at 11:41 AM
News IconResearch Analysts' Recent Ratings Updates for Qiagen NV (QGEN) - NewsDen (NASDAQ:QGEN)
newsden.net - September 23 at 11:41 AM
nasdaq.com logoQiagen Reaches Analyst Target Price - Nasdaq (NASDAQ:QGEN)
www.nasdaq.com - September 17 at 6:26 PM
realistinvestor.com logoQiagen N.V. (NASDAQ:QGEN) Is Expected To Post EPS Of $0.32 (NASDAQ:QGEN)
www.realistinvestor.com - September 13 at 11:50 AM
streetinsider.com logoQiagen (QGEN) Receives Unfavorable Decision in '537 Patent Suit - StreetInsider.com (NASDAQ:QGEN)
www.streetinsider.com - September 12 at 6:37 PM
realistinvestor.com logoA Price Target Of $25.812 Is Set By Research Analysts For Qiagen N.V. (NASDAQ:QGEN) (NASDAQ:QGEN)
www.realistinvestor.com - September 12 at 11:34 AM
realistinvestor.com logoA Price Target Of $25.812 Is Set By Research Analysts For Qiagen ... - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 11 at 6:21 PM
4-traders.com logoQIAGEN : Comments on Preliminary Injunction and Confirms Intention to Defend its U.S. Intellectual Property Position (NASDAQ:QGEN)
www.4-traders.com - September 10 at 6:12 PM
publicnow.com logoQIAGEN comments on preliminary injunction and confirms intention to defend its U.S. intellectual property position (NASDAQ:QGEN)
www.publicnow.com - September 10 at 6:12 PM
News IconStocks Gainers/Losers Roundup- Qiagen NV (NASDAQ:QGEN), Donaldson Firm (NYSE:DCI), Accenture (NYSE:ACN) - Seneca Globe (NASDAQ:QGEN)
www.senecaglobe.com - September 9 at 11:43 AM
publicnow.com logoQIAGEN welcomes U.S. guidance for latent TB testing in primary care (NASDAQ:QGEN)
www.publicnow.com - September 8 at 6:40 PM
realistinvestor.com logoAccounts Payable For Qiagen NV (NASDAQ:QGEN) Is $45.563 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 5 at 11:01 AM
investornewswire.com logoCan Shares Of Qiagen N.V. (NASDAQ:QGEN) Get To $27? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - September 3 at 6:06 PM
realistinvestor.com logoQiagen NV (NASDAQ:QGEN) Is Expected To Post EPS Of $0.32 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - August 31 at 12:09 PM
News IconThe Key Numbers To Watch From Qiagen NV (NASDAQ:QGEN)'s ... - The Voice Registrar (NASDAQ:QGEN)
voiceregistrar.com - August 25 at 12:05 PM
uk.finance.yahoo.com logoBUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern (NASDAQ:QGEN)
uk.finance.yahoo.com - August 25 at 12:05 PM
investornewswire.com logoWill Qiagen N.V. (NASDAQ:QGEN) Hit $27 Price Target? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - August 21 at 10:58 AM
News IconOctal to binary converter Germany stocks lower at close of trade; dax down 1.25% by investing. com convert usd to euro calculator (NASDAQ:QGEN)
getthatmoneyhoney.com - August 20 at 11:02 AM
investing.com logoGermany stocks higher at close of trade; DAX up 0.24% (NASDAQ:QGEN)
www.investing.com - August 15 at 7:25 PM
finance.yahoo.com logo2:05 am Qiagen proposes plans to return ~$250 mln to shareholders; Proposal would adjust capital structure through 4% reduction in number of shares outstanding and direct capital repayment to shareholders (NASDAQ:QGEN)
finance.yahoo.com - August 15 at 9:12 AM
4-traders.com logoQIAGEN : Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal (NASDAQ:QGEN)
www.4-traders.com - August 14 at 11:27 AM
finance.yahoo.com logoQIAGEN Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal (NASDAQ:QGEN)
finance.yahoo.com - August 14 at 11:27 AM
fidaily.com logoBaillie Gifford & Co Adjusts Its Position in Qiagen N.V. (QGEN) Last Quarter - Finance Daily (NASDAQ:QGEN)
www.fidaily.com - August 9 at 7:18 PM
tradecalls.org logoQiagen N.V. (QGEN) Shares are Up 0.56% - Trade Calls (NASDAQ:QGEN)
www.tradecalls.org - August 8 at 11:43 AM
fool.com logo1,750 Reasons to Like Qiagen NV (NASDAQ:QGEN)
www.fool.com - August 3 at 4:43 PM
finance.yahoo.com logoQiagen (QGEN) Tops Q2 Earnings & Sales; Margins Drop Y/Y (NASDAQ:QGEN)
finance.yahoo.com - August 1 at 10:08 AM
investing.com logoGermany stocks higher at close of trade; DAX up 0.61% (NASDAQ:QGEN)
www.investing.com - July 29 at 7:09 PM
News IconWhy Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks (NASDAQ:QGEN)
feedproxy.google.com - July 29 at 5:22 PM
investorplace.com logoWhy Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks (NASDAQ:QGEN)
investorplace.com - July 29 at 4:34 PM
finance.yahoo.com logoEdited Transcript of QGEN earnings conference call or presentation 29-Jul-16 1:30pm GMT (NASDAQ:QGEN)
finance.yahoo.com - July 29 at 3:36 PM
fool.com logoWhy Qiagen NV Jumped Higher Today (NASDAQ:QGEN)
www.fool.com - July 29 at 12:40 PM
thestreet.com logoQiagen (QGEN) Stock Soars as Q2 Results Surpass Expectations (NASDAQ:QGEN)
www.thestreet.com - July 29 at 11:26 AM
sg.finance.yahoo.com logoQiagen beats Street 2Q forecasts (NASDAQ:QGEN)
sg.finance.yahoo.com - July 28 at 5:28 PM
biz.yahoo.com logoQ2 2016 Qiagen NV Earnings Release - 4:00 pm ET (NASDAQ:QGEN)
biz.yahoo.com - July 28 at 7:07 AM
4-traders.com logoQiagen NV : launches “Digital NGS” solutions with unique Molecular Index Technology to reliably detect all genetic variation (NASDAQ:QGEN)
www.4-traders.com - July 27 at 7:25 PM
publicnow.com logoQIAGEN launches “Digital NGS” solutions with unique Molecular Index Technology to reliably detect all genetic variation (NASDAQ:QGEN)
www.publicnow.com - July 27 at 4:18 PM
publicnow.com logoQIAGEN launches novel integrated system for collection, stabilization, transport, storage and isolation of circulating cell-free DNA (NASDAQ:QGEN)
www.publicnow.com - July 27 at 4:18 PM
finance.yahoo.com logoQIAGEN Launches "Digital NGS" Solutions with Unique Molecular Index Technology to Reliably Detect All Genetic Variation (NASDAQ:QGEN)
finance.yahoo.com - July 27 at 4:07 PM
investornewswire.com logoIs $27 Price Target Attainable For Qiagen N.V. (NASDAQ:QGEN)? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - July 24 at 11:05 AM
News IconIt's Earnings Time: What to Do with Qiagen NV (NASDAQ:QGEN) Stock - The Voice Registrar (NASDAQ:QGEN)
voiceregistrar.com - July 24 at 11:05 AM
News IconShares Turning Downward: Qiagen NV (NASDAQ:QGEN) - TGP (NASDAQ:QGEN)
telanaganapress.com - July 20 at 7:53 PM
News IconQiagen NV Ord (NASDAQ:QGEN) Short Interest Increased By 14.75% - Press Telegraph (NASDAQ:QGEN)
presstelegraph.com - July 19 at 5:01 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Qiagen N.V. (NASDAQ:QGEN) - TGP (NASDAQ:QGEN)
telanaganapress.com - July 19 at 5:01 AM
finance.yahoo.com logoQiagen sees call buying before earnings (NASDAQ:QGEN)
finance.yahoo.com - July 18 at 3:07 PM
investornewswire.com logoStrong Sell Calls For Qiagen N.V. (NASDAQ:QGEN) At 0 - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - July 17 at 11:09 AM
4-traders.com logoQiagen NV : N.V. to Report Second Quarter and First Half of 2016 Results (NASDAQ:QGEN)
www.4-traders.com - July 14 at 10:38 AM
finance.yahoo.com logoQIAGEN N.V. to Report Second Quarter and First Half of 2016 Results (NASDAQ:QGEN)
finance.yahoo.com - July 14 at 5:14 AM
News IconJohnston Asset Management Corp Decreased Stake in Qiagen Nv (NASDAQ:QGEN) by $50.48 Million as Shares ... - Consumer Eagle (NASDAQ:QGEN)
www.consumereagle.com - July 13 at 7:25 PM

Social

Qiagen NV (NASDAQ:QGEN) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff